Medlive Technology Co Ltd (2192.HK)
Company Info
Highlights
HK$8.62B
25.57
1.75
HK$6.51 - HK$16.88
HK$15.93
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Medlive Technology Co Ltd (2192.HK) returned 18.43% year-to-date (YTD) and 43.70% over the past 12 months.
2192.HK
18.43%
1.38%
27.14%
43.70%
N/A
N/A
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 2192.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -12.59% | 40.55% | 7.38% | -7.63% | -2.81% | 18.43% | |||||||
| 2024 | -27.12% | 20.23% | 1.62% | 10.33% | -7.10% | -1.84% | 0.80% | 7.58% | 14.22% | -7.16% | 15.98% | 1.33% | 21.05% |
| 2023 | 26.85% | -11.46% | 13.36% | -20.26% | -20.44% | 2.52% | -6.01% | 6.54% | 13.00% | -1.39% | 27.10% | -13.29% | 1.83% |
| 2022 | -53.60% | -8.56% | -31.54% | 17.72% | -3.87% | 29.37% | -13.52% | 25.65% | -28.23% | -24.67% | 43.36% | -12.24% | -68.57% |
| 2021 | -1.13% | 7.34% | 14.44% | 7.44% | -1.85% | -31.49% | -12.26% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 77, 2192.HK is among the top 23% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Medlive Technology Co Ltd (2192.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Medlive Technology Co Ltd provided a 2.29% dividend yield over the last twelve months, with an annual payout of HK$0.27 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Dividend | HK$0.27 | HK$0.27 | HK$0.19 | HK$0.02 |
Dividend yield | 2.29% | 2.71% | 2.25% | 0.25% |
Monthly Dividends
The table displays the monthly dividend distributions for Medlive Technology Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.13 | HK$0.00 | HK$0.00 | HK$0.27 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.07 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.12 | HK$0.00 | HK$0.19 |
| 2022 | HK$0.02 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.02 |
Dividend Yield & Payout
Dividend Yield
Medlive Technology Co Ltd has a dividend yield of 2.29%, which is quite average when compared to the overall market.
Payout Ratio
Medlive Technology Co Ltd has a payout ratio of 57.44%, which is quite average when compared to the overall market. This suggests that Medlive Technology Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Medlive Technology Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Medlive Technology Co Ltd was 87.26%, occurring on Aug 16, 2023. The portfolio has not yet recovered.
The current Medlive Technology Co Ltd drawdown is 72.60%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -87.26% | Nov 12, 2021 | 433 | Aug 16, 2023 | — | — | — |
| -14.75% | Aug 13, 2021 | 11 | Aug 27, 2021 | 19 | Sep 24, 2021 | 30 |
| -12.42% | Jul 16, 2021 | 9 | Jul 28, 2021 | 9 | Aug 10, 2021 | 18 |
| -5.71% | Oct 18, 2021 | 6 | Oct 25, 2021 | 2 | Oct 27, 2021 | 8 |
| -5.52% | Oct 5, 2021 | 2 | Oct 6, 2021 | 4 | Oct 12, 2021 | 6 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Medlive Technology Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Medlive Technology Co Ltd is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 2192.HK, comparing it with other companies in the Medical Distribution industry. Currently, 2192.HK has a P/E ratio of 25.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 2192.HK compared to other companies in the Medical Distribution industry. 2192.HK currently has a PEG ratio of 1.8. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 2192.HK relative to other companies in the Medical Distribution industry. Currently, 2192.HK has a P/S ratio of 15.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 2192.HK in comparison with other companies in the Medical Distribution industry. Currently, 2192.HK has a P/B value of 1.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |